Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Itron (ITRI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Itron (ITRI) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Itron's Cash & Equivalents rose 3556.59% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 3556.59%. This contributed to the annual value of $1.1 billion for FY2024, which is 24803.53% up from last year.
  • Itron's Cash & Equivalents amounted to $1.3 billion in Q3 2025, which was up 3556.59% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Itron's Cash & Equivalents ranged from a high of $1.3 billion in Q3 2025 and a low of $162.6 million during Q4 2021
  • Over the past 5 years, Itron's median Cash & Equivalents value was $254.8 million (recorded in 2023), while the average stood at $520.2 million.
  • Per our database at Business Quant, Itron's Cash & Equivalents tumbled by 6780.93% in 2021 and then soared by 29548.56% in 2024.
  • Quarter analysis of 5 years shows Itron's Cash & Equivalents stood at $162.6 million in 2021, then grew by 24.25% to $202.0 million in 2022, then skyrocketed by 49.52% to $302.0 million in 2023, then soared by 248.04% to $1.1 billion in 2024, then grew by 26.7% to $1.3 billion in 2025.
  • Its Cash & Equivalents stands at $1.3 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.1 billion for Q1 2025.